INVESTORS AND MEDIA

CORPORATE PROFILE
Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Our unwavering commitment to advancing patient care is demonstrated every day. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.
Webcast ImageWebcast
Lazard Capital Markets Conference Call at 2013 SLEEP Meeting (Live)
06/05/13 at 12:30 p.m. ET
Download Documentation 2011 Annual Report
NEWS & EVENTS
May 13 2013 - 9:31 p.m.
Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
May 07 2013 - 4:05 p.m.
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
Apr 23 2013 - 4:05 p.m.
Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013
MORE >>

EMAIL ALERTS

Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.